N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide

N2‑[(benzyloxy)carbonyl]‑n1‑[(3S)‑1‑cyanopyrrolidin‑3‑yl]‑L-leucinamide is a synthetic small molecule belonging to the n-acyl-alpha amino acids and derivatives class. It is characterized by an acylated alpha-amino acid structure, specifically a leucine derivative with benzyloxycarbonyl and cyanopyrrolidine substituents. This compound is known as an experimental inhibitor of cathepsin K, a lysosomal cysteine protease involved in bone resorption and other physiological processes. Cathepsin K inhibitors have been investigated for potential therapeutic use in osteoporosis and other diseases involving excessive bone degradation, but this specific compound has not advanced beyond early experimental stages[2][5][1].

Other names

N2-((benzyloxy)carbonyl)-n1-((3S)-1-cyanopyrrolidin-3-yl)-l-leucinamidebenzyl N-[(1S)-1-{[(3R)-1-cyanopyrrolidin-3-yl]carbamoyl}-3-methylbutyl]carbamatebenzyl N-((1S)-1-( ( ( 3R ) - 1-cyanopyrrolidin - 3 - yl ) carbamoyl ) - 3-methylbutyl ) carbamate